Related Experiment Video
Updated: Sep 20, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
SARS-CoV-2 and probable lung cancer risk
Sajad Khiali1, Afra Rezagholizadeh1, Taher Entezari-Maleki1,2
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may promote lung cancer by acting as an oncovirus. This review explores three potential oncogenic mechanisms linked to coronavirus disease 2019 (COVID-19) and lung cancer development.
Area of Science:
- * Oncology
- * Virology
- * Respiratory Medicine
Background:
- * The global COVID-19 pandemic caused by SARS-CoV-2 presents significant mortality and morbidity.
- * Long-term complications and immunity following COVID-19 remain incompletely understood.
- * SARS-CoV-2 shares pathophysiological similarities with oncoviruses in lung tissue.
Purpose of the Study:
- * To explore the potential oncogenic mechanisms of SARS-CoV-2.
- * To investigate the association between SARS-CoV-2 infection and lung cancer development.
- * To summarize three proposed pathways through which SARS-CoV-2 may contribute to lung cancer.
Main Methods:
- * Review of existing literature on SARS-CoV-2 pathophysiology.
- * Analysis of potential oncogenic mechanisms based on viral characteristics.
- * Synthesis of evidence linking viral infection to cancer development.
Main Results:
- * SARS-CoV-2 exhibits characteristics suggesting oncoviral activity in the lungs.
- * Three distinct oncogenic mechanisms are proposed for SARS-CoV-2.
- * These mechanisms may increase the risk of lung cancer post-infection.
Conclusions:
- * SARS-CoV-2 may play a role in lung cancer development through oncogenic mechanisms.
- * Further research is crucial to elucidate the long-term oncological risks of COVID-19.
- * Understanding these mechanisms can inform future prevention and treatment strategies.
More Related Videos
Related Concept Videos
Cancer Prevention
Some...
Single Nucleotide Polymorphisms-SNPs
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Other Pulmonary Disorders
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

